There are two main treatment options for HNF1A MODY in pregnancy (Fig. 2): stop sulfonylureas pre‐pregnancy and transfer to insulin or treat with glibenclamide pre‐/early pregnancy and transfer to insulin in the second trimester. This evidence concerns the gene INS and MODY.